Exact Therapeutics AS
EXACT Therapeutics AS, a clinical stage biopharmaceutical company, develops a technology platform for targeted therapeutic enhancement, Acoustic Cluster Therapy (ACT). The ACT is an approach to ultrasound-mediated, targeted drug enhancement with the potential to amplify the clinical utility of a range of therapeutic agents across various indications, including within oncology and brain diseases. … Read more
Exact Therapeutics AS (EXTX) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of December 2024: -0.697x
Based on the latest financial reports, Exact Therapeutics AS (EXTX) has a cash flow conversion efficiency ratio of -0.697x as of December 2024.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Nkr-80.55 Million) by net assets (Nkr115.55 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Exact Therapeutics AS - Cash Flow Conversion Efficiency Trend (2017–2024)
This chart illustrates how Exact Therapeutics AS's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Exact Therapeutics AS Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Exact Therapeutics AS ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Matching Maximize Solution Public Company Limited
BK:MATCH
|
0.003x |
|
Llama Group S.A.
PA:ALLAM
|
0.411x |
|
Ameriwest Lithium Inc
PINK:AWLIF
|
0.002x |
|
InTiCa Systems AG
F:IS7
|
0.071x |
|
Generic Gold Corporation
PINK:GGCPF
|
1.217x |
|
Nationwide RV & Resorts, Inc.
PINK:NWRV
|
0.077x |
|
Afrimat
JSE:AFT
|
0.117x |
|
K2 Asset Management Holdings Ltd
AU:KAM
|
0.052x |
Annual Cash Flow Conversion Efficiency for Exact Therapeutics AS (2017–2024)
The table below shows the annual cash flow conversion efficiency of Exact Therapeutics AS from 2017 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | Nkr115.55 Million | Nkr-80.55 Million | -0.697x | +29.02% |
| 2023-12-31 | Nkr45.10 Million | Nkr-44.30 Million | -0.982x | -88.90% |
| 2022-12-31 | Nkr65.11 Million | Nkr-33.85 Million | -0.520x | +0.24% |
| 2021-12-31 | Nkr105.74 Million | Nkr-55.11 Million | -0.521x | -220.16% |
| 2020-12-31 | Nkr159.65 Million | Nkr-25.99 Million | -0.163x | +44.84% |
| 2019-12-31 | Nkr42.24 Million | Nkr-12.46 Million | -0.295x | -35.10% |
| 2018-12-31 | Nkr57.06 Million | Nkr-12.46 Million | -0.218x | +85.37% |
| 2017-12-31 | Nkr8.35 Million | Nkr-12.46 Million | -1.493x | -- |